Comprehensive NeuroScience

Oct 26, 2023

MADRID, 25 Oct. (EUROPA PRESS) – The full academician of the RANME and specialist in Neurology and Neurophysiology who directs the Comprehensive Neuroscience Center of HM Hospitales, HM CINAC, José Obeso, has highlighted that “age is the main risk factor in dementia, along with habits life, vascular aspects and literacy level. During his speech at the ‘I Symposium on Innovation and Research in Neurosciences’, promoted and promoted by the Cajal Chair within the framework of the 10th Week in honor of the Nobel Prize, Obeso stressed the importance of early diagnosis in dementia, such as basic tool for better disease progression and greater benefit for patients. The symposium was held at the Royal National Academy of Medicine of Spain (RANME) and had the collaboration of Roche Farma. At the meeting, the scientific director of the chair, Santiago Ramón y Cajal Agüeras, full academician of the RANME and coordinator of the symposium, made a brief reminder of Cajal’s most visionary ideas. “Cajal’s vision of the functioning of the nervous system through histology was and continues to be extraordinary,” said Ramón y Cajal Agüeras. During the event, the director of the Cajal International Neuroscience Center, Juan Lerma, highlighted the advances that have occurred in recent years in the diagnosis, treatment and prevention of diseases. “Many of these advances were already hinted at at the time by the illustrious doctor Santiago Ramón y Cajal,” he assured. Likewise, the experts gathered have agreed to highlight that research and innovation go hand in hand in medicine and, in the context of neurological diseases, the objective is to understand the needs of each patient, incorporate new technologies and assess the current situation. of health care. In this sense, the head of Personalized Medicine at Roche Farma Spain, Teresa Ramos, has explained how the development and approach of innovation and research has evolved towards a medicine in which the data obtained is fundamental in decisions. “Thanks to the data we extract from clinical trials, we are offered the possibility of offering more personalized, more precise, and more creative medicine when it comes to providing new solutions,” said Ramos. For her part, the CSCI Research professor and advisor to the Presidency of the Carlos III Institute – CSIC, Rosa Perona, has highlighted the importance and need to have a provision of economic funds that allow continuing research and making it a universal reality in Spain. personalized medicine, something that Santiago Ramón y Cajal Agüeras has also agreed on. “Having funds and aid is more than necessary, not only to continue researching, but also to promote the discovery of new brains, as Santiago Ramón y Cajal was,” added Ramón y Cajal Agüeras.